Cyclosporine A alleviated matrix metalloproteinase 9 associated blood-brain barrier disruption after subarachnoid hemorrhage in mice
- 31 March 2017
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 649, 7-13
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cyclosporine-A as a neuroprotective agent against stroke: Its translation from laboratory research to clinical applicationNeuropeptides, 2011
- Cyclosporin A induces hyperpermeability of the blood–brain barrier by inhibiting autocrine adrenomedullin-mediated up-regulation of endothelial barrier functionEuropean Journal of Pharmacology, 2010
- Adenosine A3 receptor agonist reduces early brain injury in subarachnoid haemorrhageNeuroReport, 2010
- Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective useExpert Opinion on Drug Safety, 2009
- P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitroEpilepsy Research, 2008
- A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat modelJournal of Neuroscience Methods, 2008
- Cyclosporin neurotoxicityBritish Journal of Haematology, 2003
- Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs.Stroke, 1990
- CyclosporineNew England Journal of Medicine, 1989
- CYCLOSPORIN METABOLITES AND NEUROTOXICITYThe Lancet, 1989